Researchers discovered all neuroblastomas arise from a single type of embryonic cell called sympathoblasts. The findings could lead to new avenues of treatment for the aggressive childhood cancer.
Reductive stress promotes protein aggregation in neuroblastoma cells and impairs neurogenesis.
Using big data, researchers have developed a new computer algorithm capable of analyzing genetic and pharmacological information to suggest new treatment options for neuroblastoma.
Karolinska Institute researchers report over-expression of the estrogen receptor causes neuroblastoma cells to mature into neuron-like cells.
A new study in Nature Communications reveals a common genetic variant that increases the risk of neuroblastoma, the most common cancer in infants.
A new study reveals how LMO1 works wih the MYCN gene to fuel the spread of neuroblastoma brain cancer.
A new study finds wine-derived human gut metabolites may have neuroprotective capabilities.
Researchers report children born from mothers who underwent fertility treatment are at higher risk of developing neoplasms and pediatric cancers.
Researchers report neuroblastoma tumors shrank in 80 percent of newly diagnosed, high risk patients involved in a clinical trail of an immunotherapy treatment.
A new study reports certain strains of the herpes virus are able to infect neurons and could underlie some symptoms of neurological disorders such as MS.
Researchers find possible markers for brain cancers in the neural crest.
Researchers report on how exosomic miRNAs released within a tumor environment affect resistance to chemotherapy.
